期刊论文详细信息
Molecules
NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
Stefano Toldo1  Eleonora Mezzaroma1  Antonio Abbate1 
[1] VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, VA 23298, USA;
关键词: NLRP3;    inflammasome;    caspase-1;    ASC;    IL-1;    IL-18;   
DOI  :  10.3390/molecules26040976
来源: DOAJ
【 摘 要 】

Virtually all types of cardiovascular diseases are associated with pathological activation of the innate immune system. The NACHT, leucine-rich repeat (LRR), and pyrin domain (PYD)-containing protein 3 (NLRP3) inflammasome is a protein complex that functions as a platform for rapid induction of the inflammatory response to infection or sterile injury. NLRP3 is an intracellular sensor that is sensitive to danger signals, such as ischemia and extracellular or intracellular alarmins during tissue injury. The NLRP3 inflammasome is regulated by the presence of damage-associated molecular patterns and initiates or amplifies inflammatory response through the production of interleukin-1β (IL-1β) and/or IL-18. NLRP3 activation regulates cell survival through the activity of caspase-1 and gasdermin-D. The development of NLRP3 inflammasome inhibitors has opened the possibility to targeting the deleterious effects of NLRP3. Here, we examine the scientific evidence supporting a role for NLRP3 and the effects of inhibitors in cardiovascular diseases.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:1次